The role of HO-1 in preventing gestational hypertension was confirmed after observing that CO application during days 3–8 could compensate for HO-1 deficiency and reversed the development of hypertension and IUGR in a mouse model (Linzke et al., 2014). The gene discussed is HMOX1; the disease is hypertensive disorder.